BioSpace News Archive

MorphoSys AG announced that its licensee Janssen Research & Development, LLC. has announced it received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency recommending the expanded use of Tremfya for the treatment of adult patients with active psoriatic arthritis in the European Union.

Leading hearing implant manufacturer MED-EL sets another revolutionary milestone in its long-standing history of technological innovations.

Kinnon Joins to Lead Development and Commercialization of First Minimally Invasive Blood-Based Prognostic Test for Early Alzheimer’s Disease

Ultimovacs ASA, announced five-year overall survival data from the Phase I trial evaluating UV1 as maintenance therapy in patients with non-small cell lung cancer.

Designation qualifies Versantis to receive FDA priority review voucher (PRV) upon marketing approval of VS-01

Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”) Presentation at the American Society of Hematology Meeting

Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., received a grant from the Bill & Melinda Gates Foundation as part of the COVID-19 Therapeutics Accelerator to enable the development and production of monoclonal antibody candidates for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries.

The 51st Zhangshu National TCM Materials and Pharmaceuticals Trade Fair sponsored by the China Association of Traditional Chinese Medicine opened in Zhangshu, a country-level city in east China’s Jiangxi Province on Friday.

Topas Therapeutics GmbH, a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction capabilities of the liver, announced the appointment of Klaus Martin, Ph.D., as Chief Executive Officer.

Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, announced the appointment of industry veteran Gregory I. Berk, MD, to its Board of Directors.